Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly’s Pipeline Programs

February 09, 2022 06:55 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and...

New Benchmark Report from NIST, Baylor College of Medicine and DNAnexus Helps Provide Accurate Identification of Variants in Challenging Medically Relevant Genes

New Nature Biotechnology publication advances efforts to improve genome sequencing information for diagnosis and treatment of diseaseFebruary 08, 2022 08:03 AM Eastern Standard Time MOUNTAIN VIEW, Calif. & HOUSTON–(BUSINESS WIRE)–Researchers from National Institute...

The Canadian Neuromuscular Disease Registry and Amylyx Pharmaceuticals Partner on Real-World Evidence Generation for a Novel Investigational Therapy in ALS with the Goal of Advancing Health Outcomes for Canadians Living with ALS

February 03, 2022 08:00 AM Eastern Standard Time CALGARY, Alberta & TORONTO–(BUSINESS WIRE)–The Canadian Neuromuscular Disease Registry (CNDR), an independent, academic registry based out of the University of Calgary, and...

EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms

CHICAGO, Feb. 3, 2022 /PRNewswire/ — EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, today announced a strategic partnership with Integra Connect, LLC, designed to support life sciences...